Trials / Completed
CompletedNCT04109404
Meningiomas and Treatment With CYPROTERONE ACETATE or Progestin
Meningiomas and Treatment With CYPROTERONE ACETATE or Progestin: Retrospective Study in Patients Followed at the CHRU of Brest
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 110 (actual)
- Sponsor
- University Hospital, Brest · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Investigators observe an increase risk of meningioma in patient treated by CYPROTERONE ACETATE or other form of progestin. Investigatorsdiscribe caractéristics of meningioma and treatement of the patients follow up in CHRU of Brest
Detailed description
Retrospective study in CHRU of brest, the investigators selected patient with history of méningioma and treated by CYPROTERONE ACETATE, CHLORMADINONE ACETATE and NOMEGESTROL ACETATE essentially The investigators excluded patient with risk factor of meningioma added at hormonal treatment exposition The investigators discribe the caractéristique of patients: age, sex, duration of the treatment, the caractéristique of the meningioma: localization, grade, hormonal receptors, treatment by surgery or radiotherapy and changing after discontinuation of treatment
Conditions
Timeline
- Start date
- 2019-02-25
- Primary completion
- 2019-06-01
- Completion
- 2019-06-01
- First posted
- 2019-09-30
- Last updated
- 2019-10-11
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04109404. Inclusion in this directory is not an endorsement.